{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:25:17Z","timestamp":1782015917988,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19TPA34860020"],"award-info":[{"award-number":["19TPA34860020"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.xphs.2022.04.007","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T02:09:04Z","timestamp":1650247744000},"page":"2525-2530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of the Emulsion Solvent Evaporation Technique Cosolvent Choice on the Loading Efficiency and Release Profile of Anti-CD47 from PLGA Nanospheres"],"prefix":"10.1016","volume":"111","author":[{"given":"Hanieh","family":"Safari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Felder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Kaczorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8728-6608","authenticated-orcid":false,"given":"Omolola","family":"Eniola-Adefeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2022.04.007_bib0001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00000441-200207000-00004","article-title":"Therapeutic applications of monoclonal antibodies","volume":"324","author":"Berger","year":"2002","journal-title":"Am J Med Sci"},{"issue":"5","key":"10.1016\/j.xphs.2022.04.007_bib0002","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri1837","article-title":"Potent antibody therapeutics by design","volume":"6","author":"Carter","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2022.04.007_bib0003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0250-474X.62229","article-title":"Monoclonal antibodies as diagnostics; an appraisal","volume":"72","author":"Siddiqui","year":"2010","journal-title":"Indian J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2022.04.007_bib0004","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/CCO.0000000000000468","article-title":"Targeting CD47 as a cancer therapeutic strategy- the cutaneous T cell lymphoma experience","volume":"30","author":"Folkes","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.xphs.2022.04.007_bib0005","doi-asserted-by":"crossref","first-page":"9105","DOI":"10.2147\/OTT.S220196","article-title":"Checkpoint CD47 function on tumor metastasis and immune therapy","volume":"12","author":"Lian","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"7614","key":"10.1016\/j.xphs.2022.04.007_bib0006","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.xphs.2022.04.007_bib0007","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14728222.2013.733699","article-title":"Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47","volume":"17","author":"Soto-pantoja","year":"2013","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.xphs.2022.04.007_bib0008","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.xphs.2022.04.007_bib0009","doi-asserted-by":"crossref","first-page":"E168","DOI":"10.21037\/jtd.2017.02.30","article-title":"Targeting CD47: The achievements and concerns of current studies on cancer immunotherapy","volume":"9","author":"Huang","year":"2017","journal-title":"J Thorac Dis"},{"issue":"4","key":"10.1016\/j.xphs.2022.04.007_bib0010","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/1078-0432.CCR-16-1700","article-title":"TTI-621 (SIRP\u03b1Fc): A CD47-blocking innate immune checkpoint inhibitor with broad antitumor activity and minimal erythrocyte binding","volume":"23","author":"Petrova","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.xphs.2022.04.007_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137345","article-title":"Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xphs.2022.04.007_bib0012","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2230-973X.96920","article-title":"Drug delivery systems: an updated review","volume":"2","author":"Tiwari","year":"2012","journal-title":"Int J Pharm Investig"},{"key":"10.1016\/j.xphs.2022.04.007_bib0013","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1038\/mtna.2015.17","article-title":"Liposome-based formulation for intracellular delivery of functional proteins","volume":"4","author":"Chatin","year":"2015","journal-title":"Mol Ther - Nucleic Acids"},{"issue":"48","key":"10.1016\/j.xphs.2022.04.007_bib0014","doi-asserted-by":"crossref","first-page":"22701","DOI":"10.1039\/C8NR05933K","article-title":"Polymer nanoparticles for the intravenous delivery of anticancer drugs: The checkpoints on the road from the synthesis to clinical translation","volume":"10","author":"Ferrari","year":"2018","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.xphs.2022.04.007_bib0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/acs.biomac.5b01335","article-title":"Intracellular delivery of charge-converted monoclonal antibodies by combinatorial design of block\/homo polyion complex micelles","volume":"17","author":"Kim","year":"2016","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.xphs.2022.04.007_bib0016","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/wnan.1414","article-title":"Vascular-targeted nanocarriers\u00a0: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases","volume":"8","author":"Kelley","year":"2016","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"7","key":"10.1016\/j.xphs.2022.04.007_bib0017","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1021\/acs.molpharmaceut.6b00015","article-title":"Drug delivery research: the invention cycle","volume":"13","author":"Park","year":"2016","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2022.04.007_bib0018","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.biomaterials.2009.11.007","article-title":"Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers","volume":"31","author":"Charoenphol","year":"2010","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.xphs.2022.04.007_bib0019","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1080\/17425247.2016.1200558","article-title":"Carriers for the tunable release of therapeutics: etymological classification and examples","volume":"13","author":"Uskokovi\u0107","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2022.04.007_bib0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcis.2018.02.030","article-title":"Modified two-step emulsion solvent evaporation technique for fabricating biodegradable rod-shaped particles in the submicron size range","volume":"518","author":"Safari","year":"2018","journal-title":"J Colloid Interface Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.04.007_bib0021","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"issue":"2","key":"10.1016\/j.xphs.2022.04.007_bib0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2022.04.007_bib0023","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2015.10.057","article-title":"Double emulsion solvent evaporation techniques used for drug encapsulation","volume":"496","author":"Iqbal","year":"2015","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2022.04.007_bib0024","first-page":"228","article-title":"The effect of variable release kinetics on Paclitaxel efficacy from a drug eluting stent in a porcine model","volume":"1","author":"Aragon","year":"2005","journal-title":"EuroIntervention J Eur Collab with Work Gr Interv Cardiol Eur Soc Cardiol"},{"issue":"4","key":"10.1016\/j.xphs.2022.04.007_bib0025","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1039\/C3NR05961H","article-title":"Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity","volume":"6","author":"Sethi","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.xphs.2022.04.007_bib0026","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jddst.2019.04.031","article-title":"Influence of formulation parameters on encapsulation of doxycycline in PLGA microspheres prepared by double emulsion technique for the treatment of periodontitis","volume":"52","author":"Ali","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1-2","key":"10.1016\/j.xphs.2022.04.007_bib0027","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-3659(00)00347-3","article-title":"Salt and cosolvent effects on ionic drug loading into microspheres using an O\/W method","volume":"70","author":"Al-maaieh","year":"2001","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.xphs.2022.04.007_bib0028","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1023\/A:1012172722246","article-title":"Stabilization of 10-Hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles","volume":"14","author":"Shenderove","year":"1997","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2022.04.007_bib0029","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/02652040500100261","article-title":"Microencapsulation of acetaminophen into poly (L-lactide) by three different emulsion solvent- evaporation methods","volume":"22","author":"Lai","year":"2005","journal-title":"J Microencapsul"},{"key":"10.1016\/j.xphs.2022.04.007_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2015.05.008","article-title":"Setup and validation of shake-flask procedures for the determination of partition coefficients (log D) from low drug amounts","volume":"76","author":"Andr\u00e9s","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.04.007_bib0031","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0939-6411(98)00012-5","article-title":"Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co- glycolide) microspheres: Influence of the encapsulation technique and polymer purity on microsphere characteristics","volume":"45","author":"Bittner","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2022.04.007_bib0032","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-3659(01)00446-1","article-title":"Effect of protein molecular weight on release from micron-sized PLGA microspheres","volume":"76","author":"Sandor","year":"2001","journal-title":"J Control Release"},{"issue":"1-2","key":"10.1016\/j.xphs.2022.04.007_bib0033","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.10.036","article-title":"Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres","volume":"334","author":"Mao","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2022.04.007_bib0034","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0927-7757(96)03809-5","article-title":"Double emulsions - Scope, limitations and new achievements","volume":"123-124","author":"Garti","year":"1997","journal-title":"Colloids Surfaces A"},{"issue":"2","key":"10.1016\/j.xphs.2022.04.007_bib0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jps.21850","article-title":"Studies on controlled release of hydrophilic drugs from W\/O high internal phase ratio emulsions","volume":"99","author":"Calder\u00f3","year":"2010","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2022.04.007_bib0036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2005.08.002","article-title":"In vivo tumor targeting of tumor necrosis factor-\u03b1-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size","volume":"27","author":"Fang","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.04.007_bib0037","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2174\/138161210791920496","article-title":"Factors that control the circulation time of nanoparticles in blood\u00a0: challenges, solutions and future prospects","volume":"16","author":"Yoo","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.xphs.2022.04.007_bib0038","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/02652040400026392","article-title":"Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique","volume":"22","author":"Dinarvand","year":"2005","journal-title":"J Microencapsul"},{"issue":"10","key":"10.1016\/j.xphs.2022.04.007_bib0039","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1073\/pnas.1418144112","article-title":"CD47 regulates the phagocytic clearance and replication of the Plasmodium yoelii malaria parasite","volume":"112","author":"Banerjee","year":"2015","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:38:42Z","timestamp":1758361122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0022354922001587"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.04.007","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the Emulsion Solvent Evaporation Technique Cosolvent Choice on the Loading Efficiency and Release Profile of Anti-CD47 from PLGA Nanospheres","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}